Journal article
Development and validation of age-specific predictive models on the risk of post-acute mortality within 1 year of COVID-19 infection
- Abstract:
- Background: The existing risk prediction models for COVID-19 associated mortality have not considered the differences in risk factors across different age groups of patients. Aim: To develop age-specific prediction models to forecast the risk of all-cause mortality in patients recovering from COVID-19 infection. Design: Population-based, retrospective cohort study. Methods: Patients with COVID-19 between 1 April 2020 and 31 July 2022 survived beyond the acute phase of infection were stratified into separate age cohorts (<45, 45–64, ≥65) and followed-up for 1 year. Backward stepwise logistic regression and four statistical and machine learning algorithms were employed to develop age-specific models on the risk of post-acute mortality following COVID-19 infection, based on a comprehensive set of clinical parameters including demographics, COVID-19 vaccination status, pre-existing comorbidities and laboratory-test findings. Results: Of the 891 246 patients with COVID-19 identified, 13 578 (1.05%) died within 1 year of the index date. Age, COVID-19 vaccination status and history of acute respiratory syndrome prior infection were identified as predictors in the models for separate age groups. The model for patients aged ≥65 exhibited excellent prediction performance with an AUROC of 0.87 (95% CI: 0.87, 0.88), followed by the model for patients aged 45–64 [AUROC = 0.83 (95% CI: 0.81, 0.85)] and those aged <45 [AUROC = 0.79 (95% CI: 0.72, 0.86)]. Conclusion: The age-specific models accurately predicted the risk of post-acute mortality in their corresponding age groups of patients, providing valuable asset in optimizing clinical strategies and resource allocation in the management of the global burden of Long COVID.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
- Publisher copy:
- 10.1093/qjmed/hcaf218
- Publication website:
- https://publications.aston.ac.uk/id/eprint/48124/1/hcaf218.pdf
Authors
+ Innovation and Technology Commission
More from this funder
- Funder identifier:
- https://ror.org/04vf9tr09
- Publisher:
- Oxford University Press
- Journal:
- QJM: An International Journal of Medicine More from this journal
- Volume:
- 119
- Issue:
- 2
- Pages:
- 117-128
- Publication date:
- 2025-09-22
- DOI:
- EISSN:
-
1460-2393
- ISSN:
-
1460-2725
- Language:
-
English
- Keywords:
- Pubs id:
-
2292800
- Local pid:
-
pubs:2292800
- Source identifiers:
-
3897965
- Deposit date:
-
2026-03-29
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
If you are the owner of this record, you can report an update to it here: Report update to this record